Volume 3, Issue 1, January 2017

Anticoagulation, atherosclerosis, and heart failure

• Extract
• View article

European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition

• Extract
• View article

The Heart Failure Association Congress confirms itself as the largest European Society of Cardiology sub-speciality congress

• Extract
• View article

With regard to the paper by Zannad et al. entitled Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment versus risk aversion

• Extract
• View article

The 2016 version of the European Guidelines on Cardiovascular Prevention

• Extract
• View article

Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients

• Abstract
• View article
• Supplementary data

Is there a ‘therapeutic window’ for antiplatelet therapy?

• Extract
• View article

Is the use of renin–angiotensin system inhibitors in patients with aortic valve stenosis safe and of prognostic benefit? A systematic review and meta-analysis

• Abstract
• View article

A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants

• Abstract
• View article
• Supplementary data

Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA₂DS₂-VASc score

• Extract
• View article

Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: Views from a workshop at the European Medicines Agency (EMA)

• Abstract
• View article

Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives

• Abstract
• View article

Plaque imaging to refine indications for emerging lipid-lowering drugs

• Abstract
• View article